Francesca Bernardini

1.3k total citations
18 papers, 349 citations indexed

About

Francesca Bernardini is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Francesca Bernardini has authored 18 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Molecular Medicine. Recurrent topics in Francesca Bernardini's work include Antibiotic Resistance in Bacteria (5 papers), Peptidase Inhibition and Analysis (4 papers) and Bacterial biofilms and quorum sensing (4 papers). Francesca Bernardini is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Peptidase Inhibition and Analysis (4 papers) and Bacterial biofilms and quorum sensing (4 papers). Francesca Bernardini collaborates with scholars based in United Kingdom, Italy and Netherlands. Francesca Bernardini's co-authors include Michael J. Warburton, Daniel Obrecht, Kerstin Moehle, John A. Robinson, Glenn E. Dale, María Diez‐Aguilar, Michael M. Tunney, Miquel B. Ekkelenkamp, Rafael Cantón and Ad C. Fluit and has published in prestigious journals such as Biochemical Journal, FEBS Letters and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Francesca Bernardini

18 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Bernardini United Kingdom 12 201 93 92 49 43 18 349
C. Hornung Germany 6 313 1.6× 28 0.3× 50 0.5× 16 0.3× 29 0.7× 6 380
Martin Stonehouse United States 8 286 1.4× 15 0.2× 55 0.6× 48 1.0× 13 0.3× 10 356
Logan D. Andrews United States 10 190 0.9× 18 0.2× 83 0.9× 9 0.2× 35 0.8× 11 331
Ahmed E. M. Elhassanny United States 12 213 1.1× 35 0.4× 12 0.1× 15 0.3× 107 2.5× 15 373
Dejian Zhou China 7 300 1.5× 22 0.2× 43 0.5× 9 0.2× 17 0.4× 9 401
Marta Pioletti Israel 6 486 2.4× 24 0.3× 62 0.7× 8 0.2× 21 0.5× 8 607
Alvin C. Y. Kuk United States 7 208 1.0× 8 0.1× 32 0.3× 22 0.4× 45 1.0× 7 308
Denis Drainas Greece 16 501 2.5× 17 0.2× 15 0.2× 15 0.3× 35 0.8× 56 649
John M. Molyneaux United States 8 350 1.7× 31 0.3× 52 0.6× 36 0.7× 73 1.7× 10 484
Sean D. Stowe United States 7 252 1.3× 61 0.7× 58 0.6× 5 0.1× 50 1.2× 9 357

Countries citing papers authored by Francesca Bernardini

Since Specialization
Citations

This map shows the geographic impact of Francesca Bernardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Bernardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Bernardini more than expected).

Fields of papers citing papers by Francesca Bernardini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Bernardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Bernardini. The network helps show where Francesca Bernardini may publish in the future.

Co-authorship network of co-authors of Francesca Bernardini

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Bernardini. A scholar is included among the top collaborators of Francesca Bernardini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Bernardini. Francesca Bernardini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Diez‐Aguilar, María, Miquel B. Ekkelenkamp, María‐Isabel Morosini, et al.. (2021). Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates. Journal of Antimicrobial Chemotherapy. 76(10). 2578–2585. 19 indexed citations
2.
Diez‐Aguilar, María, Marta Hernández-García, María‐Isabel Morosini, et al.. (2020). Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates. Journal of Antimicrobial Chemotherapy. 76(4). 984–992. 35 indexed citations
3.
Bernardini, Francesca, Glenn E. Dale, Achim Wach, & Daniel Obrecht. (2019). WS01-4 Pharmacokinetics and pharmacodynamics of murepavadin (POL7080) in neutropenic lung infection models when evaluated by aerosol administration. Journal of Cystic Fibrosis. 18. S2–S2. 7 indexed citations
4.
Melchers, Maria J., Peter Warn, Jon Hansen, et al.. (2019). Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models. Antimicrobial Agents and Chemotherapy. 63(3). 19 indexed citations
5.
Ekkelenkamp, Miquel B., Rafael Cantón, María Diez‐Aguilar, et al.. (2019). Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics. Antimicrobial Agents and Chemotherapy. 64(2). 35 indexed citations
6.
Cigana, Cristina, Francesca Bernardini, Marcella Facchini, et al.. (2016). Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia. Antimicrobial Agents and Chemotherapy. 60(8). 4991–5000. 32 indexed citations
7.
Fattorini, Simone, et al.. (2014). Nuovi dati sui Coleotteri Tenebrionidi della città di Roma (Coleoptera Tenebrionidae). 146(3). 137–137. 1 indexed citations
8.
Papaleo, Bruno, Lidia Caporossi, Francesca Bernardini, et al.. (2011). Exposure to Styrene in Fiberglass-Reinforced Plastic Manufacture. Journal of Occupational and Environmental Medicine. 53(11). 1273–1278. 10 indexed citations
9.
Tagu, Denis, Roland Marmeisse, Sébastien Rivière, et al.. (2009). Hydrophobins in ectomycorrhizas: heterologous transcription of the Pisolithus HydPt-1 gene in yeast and Hebeloma cylindrosporum. European Journal of Histochemistry. 46(1). 23–23. 2 indexed citations
10.
Obrecht, Daniel, John A. Robinson, Francesca Bernardini, et al.. (2008). Recent Progress in the Discovery of Macrocyclic Compounds as Potential Anti-Infective Therapeutics. Current Medicinal Chemistry. 16(1). 42–65. 35 indexed citations
11.
Warburton, Michael J. & Francesca Bernardini. (2002). Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes. Neuroscience Letters. 331(2). 99–102. 16 indexed citations
12.
Athanassiou, Zafiria, Oliver Zerbe, Kerstin Moehle, et al.. (2002). Macrocyclic Hairpin Mimetics of the Cationic Antimicrobial Peptide Protegrin I: A New Family of Broad-Spectrum Antibiotics. ChemBioChem. 3(11). 1126–1133. 56 indexed citations
14.
Bernardini, Francesca & Michael J. Warburton. (2001). The substrate range of tripeptidyl-peptidase I. European Journal of Paediatric Neurology. 5. 69–72. 7 indexed citations
15.
Warburton, Michael J. & Francesca Bernardini. (2001). The specificity of lysosomal tripeptidyl peptidase‐I determined by its action on angiotensin‐II analogues. FEBS Letters. 500(3). 145–148. 14 indexed citations
16.
Zeppa, Sabrina Donati, Luciana Vallorani, Lucia Potenza, et al.. (2000). Estimation of fungal biomass and transcript levels inTilia platyphyllos-Tuber borchiiectomycorrhizae. FEMS Microbiology Letters. 188(2). 119–124. 9 indexed citations
18.
Warburton, Michael J. & Francesca Bernardini. (2000). Tripeptidyl‐peptidase I deficiency in classical late‐infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity. Journal of Inherited Metabolic Disease. 23(2). 145–154. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026